REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT-Reference-Cited by-同舟云学术

REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT

Published:1987-10 Issue:8566 Volume:330 Page:983-985
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

van Holten-Verzantvoort A.Th.,Bijvoet O.L.M.,Hermans J.,Harinck H.I.J.,Elte J.W.F.,Beex L.V.A.M.,Cleton F.J.,Kroon H.M.,Vermey P.,Neijt J.P.,Blijham G.

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Osteolytic bone metastasis in breast carcinoma Pathogenesis, morbidity and bisphosphonate treatment;Elte;Eur J Cancer Clin Oncol,1986

2. The role of bone and kidney in tumour hypercalcemia and its treatment with bisphosphonate and sodium chloride;Harinck;Am J Med,1987

3. Comparative study of available medical therapy for hypercalcemia of malignancy;Mundy;Am J Med,1983

4. Companson of two parenteral diphosphonates in hypercalcemia of malignancy;Jung;Am J Med,1982

5. Place des diphosphonates dans let thérapeutique de l'ostéolyse et des hypercalcémies malignes;Delmas;Rev Rhum,1984

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational Strategies to Target Metastatic Bone Disease;Cells;2022-04-12

2. Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases;Bone Cancer;2022

3. “The use of bisphosphonates to treat skeletal complications in solid tumours”;Bone;2021-06

4. Bisphosphonates and breast cancer – From cautious palliation to saving lives;Bone;2020-11

5. Pamidronate: A model compound of the pharmacology of nitrogen-containing bisphosphonates; A Leiden historical perspective;Bone;2020-05